Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-03-17FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application from Apotex Corp. for a generic solifenacin succinate, authorizing the generic version's approva…
-
FDA approval · 2021-02-02FDA Approved: TOLTERODINE TARTRATE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved Slate Run Pharmaceuticals' generic tolterodine tartrate under an Original Application (ANDA).
-
FDA approval · 2021-01-25FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for solifenacin succinate from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2021-01-14FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Bostal LLC)
FDA approved a supplemental application for solifenacin succinate submitted by Bostal LLC.
-
FDA approval · 2021-01-06FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for solifenacin succinate from Actavis Pharma, Inc., authorizing a change related to this generic fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-12-23FDA Approved: GEMTESA — Original Application (Sumitomo Pharma America, Inc.)
FDA approved GEMTESA (vibegron) as an original application for the treatment of overactive bladder.
-
FDA approval · 2020-12-17FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original application for a generic oxybutynin chloride product from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceutical…
-
FDA approval · 2020-11-24FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for solifenacin succinate from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2020-11-05FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for solifenacin succinate (ANDA205483), confirming continued approval of the …
-
FDA approval · 2020-10-30FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for Alembic Pharmaceuticals Limited to market a generic solifenacin succinate product.
-
FDA approval · 2020-10-27FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Advagen Pharma Limited)
FDA approved the generic oxybutynin chloride tablet from Advagen Pharma Limited under an Original Application.
-
FDA approval · 2020-08-05FDA Approved: TOLTERODINE TARTRATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved tolterodine tartrate under an Original Application (ANDA) from Unichem Pharmaceuticals (USA), Inc., making a generic version of…
-
FDA approval · 2020-05-26FDA Approved: VESICARE LS — Original Application (Astellas Pharma US, Inc.)
FDA approved Vesicare LS (solifenacin succinate) under an original NDA from Astellas Pharma US, Inc. for the treatment of overactive bladder…
-
FDA approval · 2020-05-26FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Vesicare (solifenacin succinate) submitted by Astellas Pharma US, Inc. The approval results in c…
-
FDA approval · 2020-05-19FDA Approved: TOLTERODINE TARTRATE — Original Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s original application for tolterodine tartrate (generic tolterodine tartrate), a treatment for overacti…
-
FDA approval · 2020-04-23FDA Approved: TROSPIUM CHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved an original ANDA for Trospium chloride (Granules Pharmaceuticals Inc.), a generic formulation for overactive bladder. The appro…
-
FDA approval · 2020-04-06FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Leading Pharma, LLC)
FDA approved Leading Pharma, LLC's original Abbreviated New Drug Application for oxybutynin chloride, enabling a generic version of this ant…
-
FDA approval · 2020-03-13FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for oxybutynin chloride from Amneal Pharmaceuticals LLC, updating the approval of the existing gener…
-
FDA approval · 2020-03-09FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Tolterodine tartrate (Tolterodine) by Torrent Pharmaceuticals Limited.
-
FDA approval · 2020-03-09FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for tolterodine tartrate submitted by Teva Pharmaceuticals USA, Inc. This action confirms the contin…
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for an extended-release formulation of oxybutynin chloride, manufactured by Rising Pharma Holdings, …
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for the generic oxybutynin product developed by Zydus Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-28FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for oxybutynin chloride from Ajanta Pharma USA Inc., authorizing the generic oxybutynin chloride pro…
-
FDA approval · 2020-01-24FDA Approved: TOLTERODINE TARTRATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Tolterodine Tartrate under an original application for generic use by Rising Pharma Holdings, Inc., for the treatment of overac…
-
FDA approval · 2020-01-06FDA Approved: DARIFENACIN — Original Application (POLYGEN PHARMACEUTICALS INC.)
The FDA approved the original generic application for darifenacin hydrobromide, a generic version of darifenacin for overactive bladder.